Sanara MedTech Changes Fiscal Year End
Ticker: SMTI · Form: 8-K · Filed: Mar 22, 2024 · CIK: 714256
| Field | Detail |
|---|---|
| Company | Sanara Medtech Inc. (SMTI) |
| Form Type | 8-K |
| Filed Date | Mar 22, 2024 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: fiscal-year-change, filing-update
TL;DR
Sanara MedTech is changing its fiscal year end to Dec 31st, filing new financials.
AI Summary
Sanara MedTech Inc. filed an 8-K on March 22, 2024, reporting a change in its fiscal year end to December 31st. This filing also includes financial statements and exhibits, with the date of the earliest event reported being March 21, 2024. The company, formerly known as Wound Management Technologies, Inc., is based in Fort Worth, Texas.
Why It Matters
A change in fiscal year end can impact reporting schedules and financial analysis for investors, potentially affecting how the company's performance is tracked and compared over time.
Risk Assessment
Risk Level: low — This filing is primarily administrative, related to the company's fiscal reporting structure, and does not appear to involve significant operational or financial changes.
Key Players & Entities
- Sanara MedTech Inc. (company) — Registrant
- Wound Management Technologies, Inc. (company) — Former company name
- March 21, 2024 (date) — Earliest event reported date
- March 22, 2024 (date) — Filing date
- December 31 (date) — New fiscal year end
FAQ
What is the new fiscal year end for Sanara MedTech Inc.?
The new fiscal year end for Sanara MedTech Inc. is December 31.
When was this 8-K form filed?
This 8-K form was filed on March 22, 2024.
What was Sanara MedTech Inc. formerly known as?
Sanara MedTech Inc. was formerly known as Wound Management Technologies, Inc.
What is the state of incorporation for Sanara MedTech Inc.?
Sanara MedTech Inc. is incorporated in Texas.
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report amendments to articles of incorporation or bylaws and to provide financial statements and exhibits, including a change in the company's fiscal year.
Filing Stats: 1,364 words · 5 min read · ~5 pages · Grade level 20 · Accepted 2024-03-22 16:15:41
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value SMTI The Nasdaq Capital M
Filing Documents
- form8-k.htm (8-K) — 70KB
- ex3-1.htm (EX-3.1) — 259KB
- 0001493152-24-010985.txt ( ) — 543KB
- smti-20240321.xsd (EX-101.SCH) — 3KB
- smti-20240321_lab.xml (EX-101.LAB) — 33KB
- smti-20240321_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 22, 2024 Sanara MedTech Inc . By: /s/ Michael D. McNeil Name: Michael D. McNeil Title: Chief Financial Officer